Shoseiryuto May Prevent Bronchial Epithelial Tight Junction Disruption by Inhibiting the Inflammatory NF-κB Signaling Pathway
Biology · 11.04.2026 · 15 (8) · 603
DOI: 10.3390/biology15080603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, online erschienen am 11.04.2026. Verfasst von Jingya Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Shoseiryuto (SST) is a Kampo medicine widely used to treat respiratory diseases. We previously showed that SST attenuates lipopolysaccharide (LPS)-induced tight junction (TJ) barrier disruption in human bronchial epithelial (16HBE) cells. However, the underlying mechanisms remain unclear. This study aimed to clarify the mechanisms underlying the protective effects of SST. SST attenuated inflammatory responses (increased IL-6 protein and mRNA levels) and TJ disruption (decreased transepithelial electrical resistance, increased sodium fluorescein permeability, and decreased occludin mRNA and protein expression) induced by LPS, hydrogen peroxide (H2O2), tumor necrosis factor-α (TNF-α), and polyinosinic–polycytidylic acid (Poly I:C). Further analyses using the Poly I:C model confirmed that the effects of SST were comparable to those of the nuclear factor κB (NF-κB) inhibitors SC-514 and BAY11-7085. SST reduced the activation of NF-κB signaling (increased phosphorylation of NF-κB and IκB), similar to BAY11-7085. SST components, isoliquiritigenin (ILQG) and glycyrrhizin (GL), also attenuated inflammation, barrier dysfunction, and NF-κB signaling activity. These findings suggest that (1) activation of the NF-κB signaling pathway might be associated with both inflammatory responses and TJ barrier disruption; (2) SST could reduce these effects, potentially through modulation of NF-κB signaling; and (3) ILQG and GL may contribute, in part, to these activities. Overall, this study provides the first evidence suggesting that SST may exert anti-inflammatory and epithelial barrier-protective effects, possibly via the suppression of the NF-κB signaling pathway.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
- International Collaborative Research Administration, Juntendo University School of Medicine, Tokyo 113-8431, Japan.
ORCID-Profile: Jingya Lu, Ailing Hu, Zenji Kawakami, Hiroyuki Kobayashi
Zitieren
APA
Lu, J., Hu, A., Lin, Y., Luo, Y., Yuan, W., Yamaguchi, T., Kawakami, Z., Ikarashi, Y., Abe, M., Orita, H., & Kobayashi, H. (2026). Shoseiryuto May Prevent Bronchial Epithelial Tight Junction Disruption by Inhibiting the Inflammatory NF-κB Signaling Pathway. Biology, 15(8), 603. https://doi.org/10.3390/biology15080603
Vancouver
Lu J, Hu A, Lin Y, Luo Y, Yuan W, Yamaguchi T, et al. Shoseiryuto May Prevent Bronchial Epithelial Tight Junction Disruption by Inhibiting the Inflammatory NF-κB Signaling Pathway. Biology. 2026;15(8):603. doi:10.3390/biology15080603
BibTeX
@article{Lu2026,
author = {Lu, Jingya and Hu, Ailing and Lin, Yunhai and Luo, Yi and Yuan, Wenshu and Yamaguchi, Takuji and Kawakami, Zenji and Ikarashi, Yasushi and Abe, Masaaki and Orita, Hajime and Kobayashi, Hiroyuki},
title = {Shoseiryuto May Prevent Bronchial Epithelial Tight Junction Disruption by Inhibiting the Inflammatory NF-κB Signaling Pathway},
journal = {Biology},
year = {2026},
volume = {15},
number = {8},
pages = {603},
doi = {10.3390/biology15080603}
}
EUVIMED